Aptose Biosciences
$2.609876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$2.60
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$0.04 (-1.52%) Today
$0.00 (0.00%) As of 4:00 PM EDT after-hours
Why Robinhood?
You can buy or sell APTO and other stocks, options, ETFs, and crypto commission-free!
About APTO
Aptose Biosciences, Inc. Common Shares, also called Aptose Biosciences, is a clinical-stage oncology company, which engages in the discovery, research, and development of anti-cancer therapies. Read More Its product pipeline includes APTO-253, a small molecule that induces expression of the Kruppel-Like Factor 4 genes; and CG-806 a non-covalent small molecule therapeutic agent. The company was founded on September 5, 1986 and is headquartered in Toronto, Canada.
Employees
24
Headquarters
Toronto, Ontario
Founded
1986
Market Cap
114.23M
Price-Earnings Ratio
—
Dividend Yield
0.00
Average Volume
153.12K
High Today
$2.68
Low Today
$2.53
Open Price
$2.63
Volume
110.04K
52 Week High
$3.13
52 Week Low
$1.57
Collections
Price Paid on Robinhood
10% Higher
Right Now
52 Week Low
$1.57
Average Price Paid
$2.36
52 Week High
$4.55
APTO Earnings
-$0.23
-$0.19
-$0.16
-$0.12
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Estimated
—
Actual
Expected Nov 5, After Hours